Home › Grants › United States › Exploratory Clinical Neuroscience Research on Substance Use Disorders

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including...

Grant (non-repayable) Open now

Funder

National Institutes of Health
Funder profile and all of its programs

Amount

Award amounts are not published in the listing; see the official page.

Where

United States (federal)

Eligibility

Open to businesses, self-employed people, nonprofits, colleges, universities, schools or research institutions and state, provincial, local or tribal governments. No cost sharing is required.

Sectors

Health and life sciences, Nonprofits and charities, Research and science

Deadline

Closes 16 June 2028

Source

Grants.gov XML extract (PAR-27-053)

Last checked

2 November 2026

Funder contacts

Public organizational contacts on file Unlock full profile / Sign up

Official page ↗

From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.

Related grant lists

Health and life sciences Nonprofits and charities Research and science Governments and public bodies Schools, colleges and research institutions Nonprofits and charities United States United States (national) Federal agency June 2028

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.